Main Navigation

Quick Links

Startup news: The latest out of Salarius and Recursion

U Startup News with Recursion and Salarius logos

University of Utah startups continue innovating and discovering solutions to today’s unmet needs. Here’s a roundup of some of the latest news out of these companies:

Salarius Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Salarius Pharmaceuticals logo

Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company using protein inhibition and protein degradation to develop cancer therapies for patients in need of new treatment options, reported financial results for the three and 12 months ended December 31, 2022 and provided a business update.

Recursion Publishes Second Annual Environmental, Social and Governance Report

Recursion logo

Recursion (Nasdaq: RXRX), a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery, today announced the release of its second annual Environmental, Social and Governance (ESG) Report. The report highlights the company’s approach, practices and goals in several important areas such as its commitment to patients, social and community impact, people and culture, environmental sustainability, and governance.

Oh, hello!

Contact Form